Chaparro-Solano, Henry Mauricio; Teixeira-Dos-Santos, Daniel; Waldo, Emily; Leal, Thiago P.; Inca-Martinez, Miguel; Alcauter, Sarael; Medina-Rivera, Alejandra; Ruiz-Contreras, Alejandra E.; Cornejo Olivas, Mario; Mejia-Rojas, Koni; Armas, Cintia; Chaná Cuevas, Pedro; Rojas, Natalia; Orozco, Jorge L.; Muñoz Ospina, Beatriz; Aguillón, David; Buritica, Omar; Moreno Masmela, Sonia; Merello, Marcelo
(IOS Press, 2026-04-17)
BackgroundAlthough levodopa is the gold standard treatment for Parkinson's disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, ...